The point of care blood testing devices market is projected to grow from USD 21.2 billion in 2025 to USD 61.8 billion by 2035, at a CAGR of 11.3%. Diabete POC Analyzer will dominate with a 34.6% market share, while hand-held devices will lead the technology segment with a 38.9% share.